Irritable Bowel Syndrome Treatment Market by Type, End-user & Geography, 2016 - 2022
The market of irritable bowel syndrome treatment is witnessing positive growth owing to establishment of well-defined diagnosis criteria and exploration of novel therapeutic classes by the key market players.
The market of irritable bowel syndrome treatment is witnessing positive growth owing to establishment of well-defined diagnosis criteria and exploration of novel therapeutic classes by the key market players.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Irritable</strong> <strong>Bowel</strong> <strong>Syndrome</strong> <strong>Treatment</strong> <strong>Market</strong> <strong>by</strong><br />
<strong>Type</strong>, <strong>End</strong>-<strong>user</strong> & <strong>Geography</strong>, <strong>2016</strong> – <strong>2022</strong>
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
About Us<br />
Persistence <strong>Market</strong> Research (PMR) is a market intelligence company, providing global business information<br />
reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forwardlooking<br />
insight for thousands of decision makers. We have an experienced team of Analysts, Researchers,<br />
and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze<br />
information. Our business offerings represent the latest and the most reliable information indispensable for<br />
businesses to sustain a competitive edge.<br />
Each PMR Syndicated Research report covers a different sector - such as pharmaceuticals, chemical,<br />
energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports<br />
provide in-depth analysis and deep segmentation to possible micro levels. With a wider scope and stratified<br />
research methodology, our syndicated reports strive to serve clients and satisfy their overall research<br />
requirement.<br />
Copyright © 2015 Persistence <strong>Market</strong> Research<br />
All Rights Reserved. This document contains highly confidential information and is the sole property of PMR.<br />
No part of it may be circulated, copied, quoted, or otherwise reproduced without the approval of PMR.<br />
<strong>Irritable</strong> <strong>Bowel</strong> <strong>Syndrome</strong> <strong>Treatment</strong> <strong>Market</strong>, <strong>2016</strong> - <strong>2022</strong> Page |
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
Report Media Releases<br />
<strong>Irritable</strong> <strong>Bowel</strong> <strong>Syndrome</strong> <strong>Treatment</strong> <strong>Market</strong> <strong>by</strong> <strong>Type</strong>, <strong>End</strong>-<strong>user</strong> &<br />
<strong>Geography</strong>, <strong>2016</strong> - <strong>2022</strong><br />
<strong>Irritable</strong> bowel syndrome is a functional gastrointestinal disorder of gut that may be characterized <strong>by</strong> colon muscle<br />
contractions. <strong>Irritable</strong> bowel syndrome affects the large intestine. <strong>Irritable</strong> bowel syndrome is associated with<br />
malfunctioning of the bowel and majorly occurs in elder population. Constipation, diarrhea, abdominal pain, alteration<br />
and discomfort in bowel function and bloating are some of the common symptoms of irritable bowel syndrome. Blood<br />
test and endoscopy are normally performed to detect this syndrome. <strong>Irritable</strong> bowel syndrome is a common disorder.<br />
There is no complete cure for the irritable bowel syndrome. Medicines used in irritable bowel syndrome are effective in<br />
decreasing the symptoms.<br />
Request to view TOC : http://www.persistencemarketresearch.com/toc/9938<br />
The market of irritable bowel syndrome treatment is witnessing positive growth owing to establishment of well-defined<br />
diagnosis criteria and exploration of novel therapeutic classes <strong>by</strong> the key market players. Additionally, change in lifestyle<br />
and eating habits increases the incidence of this disorder that may escalate the use of this treatment and hence drive<br />
the market growth. However, lack of specific treatment which treat all the symptoms of this disorder may restrain the<br />
growth of this market. In addition, higher competition among the key players in terms of pricing is anticipated to hamper<br />
overall growth of this market.<br />
<strong>Irritable</strong> bowel syndrome market is classified on the basis of type, end <strong>user</strong> and geography.<br />
Based on the type, the global irritable bowel syndrome market is segmented into the following:<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<strong>Irritable</strong> <strong>Bowel</strong> <strong>Syndrome</strong> with Constipation<br />
<strong>Irritable</strong> <strong>Bowel</strong> <strong>Syndrome</strong> with Diarrhea<br />
<strong>Irritable</strong> <strong>Bowel</strong> <strong>Syndrome</strong> with alternating Constipationand Diarrhea<br />
Based on the end <strong>user</strong>, the global <strong>Irritable</strong> bowel syndrome market is segmented into the following:<br />
Hospitals<br />
Clinics<br />
Homecare settings<br />
Depending on geographic regions, global irritable bowel syndrome treatment market is segmented into five key regions:<br />
North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Geographically, North America dominates<br />
the global irritable bowel syndrome treatment market. High degree of therapeutic needs and penetration of generic<br />
drugs in North American market is anticipated to drive the growth of this market. Meanwhile, Europe is considered as<br />
the second largest market owing to the large patient population undergoing diagnosis of irritable bowel syndrome<br />
coupled with the increasing demand for treatment. Launch of novel drugs with improved efficacy which provide<br />
sustained relief from irritable bowel syndrome in APAC region primarily drives the growth of this market. In addition,<br />
growing awareness regarding chronic nature of irritable bowel syndrome among the people will further drive the growth<br />
of this market in APAC region.<br />
Increased awareness about available treatment among the patients, medical community is one of the major driver in<br />
global irritable bowel syndrome treatment market.Increase in the number of patients, rise in the aging population,<br />
increasing demand for efficiency, increase in the incidence and prevalence of irritable bowel syndrome cases and<br />
increase in awareness, the global irritable bowel syndrome market is expected to have a healthy growth rate in the<br />
forecast period.<br />
<strong>Irritable</strong> <strong>Bowel</strong> <strong>Syndrome</strong> <strong>Treatment</strong> <strong>Market</strong>, <strong>2016</strong> - <strong>2022</strong> Page |
P e r s i s t e n c e M a r k e t R e s e a r c h<br />
Various key players dominating the global irritable bowel syndrome treatment market comprise Valeant<br />
Pharmaceuticals International Inc., Sucampo Pharmaceuticals, Inc., Abbott Laboratories, Lexicon Pharmaceuticals,<br />
Salix Pharmaceuticals, Ironwood Pharmaceuticals, Inc., and GlaxoSmithKline plc. Allergan Plc. among others.<br />
The report covers exhaustive analysis on:<br />
<strong>Irritable</strong> <strong>Bowel</strong> <strong>Syndrome</strong> <strong>Market</strong> Segments<br />
<strong>Irritable</strong> <strong>Bowel</strong> <strong>Syndrome</strong> <strong>Market</strong> Dynamics<br />
Historical Actual <strong>Market</strong> Size, 2013 - 2015<br />
<strong>Irritable</strong> <strong>Bowel</strong> <strong>Syndrome</strong> <strong>Market</strong> Size & Forecast <strong>2016</strong> to <strong>2022</strong><br />
<strong>Irritable</strong> <strong>Bowel</strong> <strong>Syndrome</strong> Current Trends/Issues/Challenges<br />
Competition & Companies involved<br />
<strong>Irritable</strong> <strong>Bowel</strong> <strong>Syndrome</strong> Drivers and Restraints<br />
Regional analysis includes<br />
North America<br />
Latin America<br />
Europe<br />
Asia Pacific<br />
Middle East & Africa<br />
Request to view Sample Report : http://www.persistencemarketresearch.com/samples/9938<br />
Report Highlights:<br />
Shifting Industry dynamics<br />
In-depth market segmentation<br />
Historical, current and projected industry size Recent industry trends<br />
Key Competition landscape<br />
Strategies of key players and product offerings<br />
Potential and niche segments/regions exhibiting promising growth<br />
A neutral perspective towards market performance<br />
For information regarding permissions, contact:<br />
Persistence <strong>Market</strong> Research<br />
90 Sate Street, Suite 700 Albany, NY 12207<br />
Tel: +1-518-618-1030<br />
Email: sales@persistencemarketresearch.com<br />
Website: http://www.persistencemarketresearch.com/<br />
media@persistencemarketresearch.com<br />
<strong>Irritable</strong> <strong>Bowel</strong> <strong>Syndrome</strong> <strong>Treatment</strong> <strong>Market</strong>, <strong>2016</strong> - <strong>2022</strong> Page |